Search Results - P. Kelly Marcom
- Showing 1 - 3 results of 3
-
1
A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer by John H. Strickler, Christel N. Rushing, Donna Niedzwiecki, Abigail McLeod, Ivy Altomare, Hope E. Uronis, S. David Hsu, S. Yousuf Zafar, Michael A. Morse, David Z. Chang, James L. Wells, Kimberly L. Blackwell, P. Kelly Marcom, Christy Arrowood, Emily Bolch, Sherri Haley, Fatima A. Rangwala, Ace J. Hatch, Andrew B. Nixon, Herbert I. Hurwitz
Published in BMC Cancer (2019-11-01)Get full text
Article -
2
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients by Costanza Paoletti, Meredith M. Regan, Samuel M. Niman, Emily M. Dolce, Elizabeth P. Darga, Minetta C. Liu, P. Kelly Marcom, Lowell L. Hart, John W. Smith, Karen L. Tedesco, Eitan Amir, Ian E. Krop, Angela M. DeMichele, Pamela J. Goodwin, Margaret Block, Kimberly Aung, Martha E. Brown, Robert T. McCormack, Daniel F. Hayes
Published in npj Breast Cancer (2021-06-01)Get full text
Article -
3
Returning Individual-Level Urgent or Emergent Research Results to Participants: The Project Baseline Health Study Experience by Neha Pagidipati, Brooke Heidenfelder, Lydia Coulter Kwee, Fatima Rodriguez, Ranee Chatterjee, Kishan S. Parikh, Michel G. Khouri, Jennifer Stiller, Julie Eckstrand, P. Kelly Marcom, Priyatham S. Mettu, Glenn J. Jaffe, Sumana Shashidhar, Susan Swope, Susan Spielman, Elizabeth Fraulo, L. Kristin Newby, Pamela Douglas, Charlene Wong, Robert Green, Scarlet Shore, Jessica Mega, Adrian Hernandez, Paul Campbell, Kenneth W. Mahaffey, Svati H. Shah
Published in American Journal of Medicine Open (2025-06-01)Get full text
Article